Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06531668 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women
A NA study of Hormone Regulation, sponsored by Scale Media.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06531668: Active NA study of Hormone Regulation, sponsored by Scale Media.
NCT06531668 is a NA study of Hormone Regulation that is active but no longer recruiting, run by Scale Media. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06531668, a NA study of Hormone Regulation, is active but no longer recruiting, sponsored by Scale Media.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, triple-blind, placebo-controlled trial will evaluate the efficacy of Live Conscious's Beyond Hormone supplement in regulating hormone production in women. The study involves 50 generally healthy female participants aged 25-45 who are not menopausal. The trial spans three menstrual cycles and assesses both objective hormone levels and subjective well-being through blood tests and questionnaires, respectively.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Beyond Hormone
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2024-09-07 |
| Phase | NA |
What the registry record for NCT06531668 still lists
NCT06531668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hormone Regulation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06531668 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06531668 about?
NCT06531668 is a clinical study titled "A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women". This randomized, triple-blind, placebo-controlled trial will evaluate the efficacy of Live Conscious's Beyond Hormone supplement in regulating hormone production in women. The study involves 50 generally healthy female participants aged 25-45 who are not menopausal. The trial spans three menstrual c...
What is the current status of trial NCT06531668?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-06-07. Estimated completion is 2024-09-07.
What conditions does trial NCT06531668 study?
This clinical trial studies the following conditions: Hormone Regulation.
What interventions are being tested in trial NCT06531668?
The interventions under investigation include: Placebo (OTHER), Beyond Hormone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06531668?
This trial is sponsored by Scale Media, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06531668 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06531668's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI